Gene splicing reduces effectiveness of CD20-targeting monoclonal antibodies designed to treat variety of blood cancers and disorders
Philadelphia, November 16, 2023 – Immunotherapies that target the CD20 antigen have revolutionized how patients with a variety of blood ...